BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36869001)

  • 1. New tools for bone health assessment in secreting pituitary adenomas.
    Uygur MM; Frara S; di Filippo L; Giustina A
    Trends Endocrinol Metab; 2023 Apr; 34(4):231-242. PubMed ID: 36869001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on vertebral fractures in pituitary diseases: from research to clinical practice.
    Carrone F; Ariano S; Piccini S; Milani D; Mirani M; Balzarini L; Lania AG; Mazziotti G
    Hormones (Athens); 2021 Sep; 20(3):423-437. PubMed ID: 33606197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paternal deprivation prior to adolescence and vulnerability to pituitary adenomas.
    Sobrinho LG; Duarte JS; Paiva I; Gomes L; Vicente V; Aguiar P
    Pituitary; 2012 Jun; 15(2):251-7. PubMed ID: 21701822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risks of overlooking the diagnosis of secreting pituitary adenomas.
    Brue T; Castinetti F
    Orphanet J Rare Dis; 2016 Oct; 11(1):135. PubMed ID: 27716353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of non-traumatic vertebral fractures in Cushing's syndrome patients.
    Apaydın T; Yavuz DG
    J Endocrinol Invest; 2021 Aug; 44(8):1767-1773. PubMed ID: 33420960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.
    Pirker W; Riedl M; Luger A; Czech T; Rössler K; Asenbaum S; Angelberger P; Kornhuber J; Deecke L; Podreka I; Brücke T
    J Nucl Med; 1996 Dec; 37(12):1931-7. PubMed ID: 8970508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis.
    Ribeiro de Moura C; Campos Lopes S; Monteiro AM
    Pituitary; 2022 Dec; 25(6):780-794. PubMed ID: 35867180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinemia Due to Prolactinoma has an Adverse Impact on Bone Health with Predominant Impact on Trabecular Bone: A Systematic Review and Meta-Analysis.
    Nagendra L; Dutta D; Mondal S; Kapoor N; Joshi A; Bhattacharya S
    J Clin Densitom; 2024; 27(1):101453. PubMed ID: 38064881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approaches to bone comorbidity in Cushing's disease: an update.
    Frara S; di Filippo L; Doga M; Loli P; Casanueva FF; Giustina A
    Pituitary; 2022 Oct; 25(5):754-759. PubMed ID: 35849272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas.
    Biller BM; Colao A; Petersenn S; Bonert VS; Boscaro M
    BMC Endocr Disord; 2010 May; 10():10. PubMed ID: 20478050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of the alpha-subunit of glycoprotein hormones by pituitary adenomas.
    Landolt AM; Heitz PU; Zenklusen HR
    Pathol Res Pract; 1988 Sep; 183(5):610-2. PubMed ID: 2467270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study.
    Claessen KM; Kroon HM; Pereira AM; Appelman-Dijkstra NM; Verstegen MJ; Kloppenburg M; Hamdy NA; Biermasz NR
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4808-15. PubMed ID: 24081732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-surgical management of hormone-secreting pituitary tumors.
    Patil CG; Hayden M; Katznelson L; Chang SD
    J Clin Neurosci; 2009 Aug; 16(8):985-93. PubMed ID: 19443220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of vertebral fractures and serum sclerostin levels in acromegaly.
    Uygur MM; Yazıcı DD; Buğdaycı O; Yavuz DG
    Endocrine; 2021 Sep; 73(3):667-673. PubMed ID: 34019235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas.
    Mazziotti G; Mancini T; Mormando M; De Menis E; Bianchi A; Doga M; Porcelli T; Vescovi PP; De Marinis L; Giustina A
    Pituitary; 2011 Dec; 14(4):299-306. PubMed ID: 21301967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone secretion by pituitary adenomas is characterized by increased disorderliness and spikiness but more regular pulsing.
    Roelfsema F; Pereira AM; Biermasz NR; Veldhuis JD
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3836-44. PubMed ID: 25014002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired Bone Microarchitecture in Premenopausal Women With Acromegaly: The Possible Role of Wnt Signaling.
    Silva PPB; Pereira RMR; Takayama L; Borba CG; Duarte FH; Trarbach EB; Martin RM; Bronstein MD; Tritos NA; Jallad RS
    J Clin Endocrinol Metab; 2021 Aug; 106(9):2690-2706. PubMed ID: 33871626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary tumors and gamma knife surgery. Clinical experience with more than two years of follow-up.
    Martinez R; Bravo G; Burzaco J; Rey G
    Stereotact Funct Neurosurg; 1998 Oct; 70 Suppl 1():110-8. PubMed ID: 9782242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary diseases and bone.
    Mazziotti G; Chiavistelli S; Giustina A
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):171-80. PubMed ID: 25732653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.